SCHEMBL8569

SCHEMBL8569

Cc1ccccc1-c1c(CCn2cnc3c(N)ncnc32)oc2ccccc2c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 11/20 0.53
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
HPGD P15428 1/20 0.51
ADORA2A P29274 4/20 0.48
ADORA2B P29275 1/20 0.42
ADORA1 P30542 1/20 0.42
PIK3R1 P27986 2/20 0.42
PIK3CB P42338 1/20 0.42
PIK3CG P48736 1/20 0.42
EGFR P00533 2/20 0.41
PI4KA P42356 1/20 0.40
PI4K2B Q8TCG2 1/20 0.40
PI4K2A Q9BTU6 1/20 0.40
PI4KB Q9UBF8 1/20 0.40
ERBB2 P04626 1/20 0.40
BRAF P15056 1/20 0.40
KDR P35968 1/20 0.40
TEK Q02763 1/20 0.40
AURKB Q96GD4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15689097 0.89 ADORA2A (0.48) PIK3CDLMNASMN1; SMN2HPGDADORA2A
SCHEMBL15688607 0.87 ADORA2A (0.55) PIK3CDLMNASMN1; SMN2HPGDADORA2A
SCHEMBL8117 0.84 ADORA2A (0.49) LMNASMN1; SMN2HPGDADORA2AADORA2B
SCHEMBL8479 0.84 ADORA2A (0.44) PIK3CDLMNASMN1; SMN2HPGDADORA2A
SCHEMBL19113768 0.83 PIK3CD (0.55) PIK3CDLMNASMN1; SMN2HPGDADORA2A
SCHEMBL8842 0.83 ADORA2A (0.47) LMNASMN1; SMN2HPGDADORA2AADORA2B
SCHEMBL7727 0.82 ADORA2A (0.47) PIK3CDLMNASMN1; SMN2HPGDADORA2A
SCHEMBL9569 0.81 ADORA2A (0.50) PIK3CDLMNASMN1; SMN2HPGDADORA2A
SCHEMBL9366 0.81 PIK3CD (0.54) PIK3CDLMNASMN1; SMN2HPGDADORA2A
SCHEMBL30670799 0.81 PIK3CD (0.54) PIK3CDLMNASMN1; SMN2HPGDADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2916868-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A PI3 DELTA OR DUAL PI3 DELTA-GAMMA KINASE INHIBITOR Rhizen Pharmaceuticals S.A. (CH) 2015-09-16 EP disclosed
WO-2014072937-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A PI3 DELTA OR DUAL PI3 DELTA-GAMMA KINASE INHIBITOR RHIZEN PHARMACEUTICALS SA (CH) 2014-05-15 WO disclosed
EP-2496567-A2 NOVEL BENZOPYRAN KINASE MODULATORS Rhizen Pharmaceuticals S.A. (CH) 2012-09-12 EP disclosed
WO-2011055215-A2 NOVEL KINASE MODULATORS INCOZEN THERAPEUTICS PVT. LTD. (IN) 2011-05-12 WO disclosed